Who is sponsoring NCT01644448?

NCT01644448 is sponsored by Kasiak Research Pvt. Ltd..

What condition does NCT01644448 study?

NCT01644448 studies Periorbital Hyperpigmentation (Dark Circles).

What drugs are being tested in NCT01644448?

Interventions: Autologous Human Platelet Lysate, Standard Therapy.

What is the status of NCT01644448?

NCT01644448 is currently UNKNOWN.

Last reviewed 2012-07-24 · How we verify

A Prospective Multicentric Open Label Randomized Bio-Interventional Phase I/II Pilot Study To Evaluate Safety & Efficacy Of Autologous Human Platelet Lysate (HPL) for Treatment of Periorbital Hyperpigmentation (Dark Circles)

NCT01644448 Phase 1/Phase 2 UNKNOWN

This is a multicentre, open label, randomized, pilot study to evalute safety and efficacy of Human Platelet Lysate (HPL) in subjects with Periorbital Hyperpigmentation. The study is being conducted at 2 centers in India.The primary endpoints are Physicians and Patient Self assessment score. The secondary endpoints are improvement in photographic assessment form randomization to end of study.

Details

Lead sponsor	Kasiak Research Pvt. Ltd.
Phase	Phase 1/Phase 2
Status	UNKNOWN
Enrolment	20
Start date	2012-03
Completion	2012-11

Conditions

Periorbital Hyperpigmentation (Dark Circles)

Interventions

Autologous Human Platelet Lysate
Standard Therapy

Primary outcomes

Photographic Assessment — Day 0, Month 1, Month 2, End of Study - 3 months

Countries

India